Table 1.
Initial screen population characteristics
| Baseline characteristics | |
|---|---|
| Weight (kg) | 103.1 ± 3.39 |
| Height (m) | 1.70 ± 0.02 |
| Body mass index (kg/m2) | 36.0 ± 1.27 |
| Systolic blood pressure (mm Hg) | 128.95 ± 2.60 |
| Diastolic blood pressure (mm Hg) | 81.81 ± 2.18 |
| MAP (mm Hg) | 97.51 ± 2.06 |
| Antihypertensive therapy | |
| None (%) | 14.3 |
| One-drug regimen (%) | 71.4 |
| Two-drug regimen (%) | 14.3 |
| 25(OH)D (ng/ml) | 16.55 ± 1.93 |
| PTH (pg/ml) | 47.86 ± 6.69 |
| Hemoglobin A1c (%) | 6.03 ± 0.08 |
| Thyroid-stimulating hormonea | 1.84 ± 0.20 |
| Serum creatinine (mg/dl) | 0.93 ± 0.04 |
| Low-density lipoprotein (mg/dl) | 131.77 ± 6.69 |
| Serum calcium (mg/dl)b | 9.37 ± 0.11 |
Characteristics of the study population were obtained at the first screening visit (prior to medication washout). Data are presented as means ± sem.
a
Normal range 0.5–5.0 mIU/liter.
b
Normal range 8.7–10.2 mg/dl.